Flagship · Bulletin

Macro rationale

Macro digest confirms NEUTRAL: VIX flat at 200d, HY OAS at the 18th percentile (complacent but unstressed), QQQ +6.38% still 162bp short of the +8% extension trigger — no cash escalator fires, base band ceiling 15%. Late-cycle backbone (57K payrolls, 1.7% GDPNow, hawkish Fed with FOMC July 28-29 and 9/18 dots leaning hike) plus the brief's defensive tilt justify holding near band top. This run is an event-driven, scope-locked concentration-cure patch: the §2 AI-load look-through breached its 30% early-warning trigger at 33.29% of NAV, auto-firing a mandate to trim the most concentrated AI-correlated names. That is a mechanical diversification action, not a regime shift or thesis break — every scoped name's funder remains intact or strengthening (MU score 87, TSM 86, copper at ATH). stale_policy=YES blocks any add/redeploy, so proceeds bank to cash inside the band.

Thesis

Event-driven, scope-locked concentration-cure patch. The §2 AI-load look-through breached its 30% early-warning trigger at 33.29% of NAV, auto-firing a mandate to trim the most concentrated AI-correlated names toward diversification. Scope is [ANET,ASML,AVGO,CCJ,GEV,LUNR,MP,MU,NVDA,TSM,SCCO,NEM]; everything else holds verbatim at delta 0. My read: this is a mechanical diversification action, NOT a thesis break or regime shift — every scoped funder is intact or strengthening (MU score 87, TSM 86, copper at ATH, NEM 88). The two cleanest levers are the two largest AI-load positions: SCCO (8.30%, copper at record highs — the position briefing explicitly flags harvest) trimmed -3.0pp to 5.30%, and TSM (7.28%, largest single compute name, up strongly) right-sized -2.0pp to 5.28%. Both remain substantial core/hedge positions — this is right-sizing for the §2 cap, not a durability exit. That -5pp of AI-name weight (TSM counts fully toward AI-load, SCCO partially) pulls the look-through comfortably back under 30%. stale_policy=YES blocks any redeploy, so proceeds bank to cash at the 15% band ceiling — defensive-appropriate into the July 28-29 FOMC. Two trims only; no other discretionary changes.

Reflection

Concentration escalator, not a flow break: AI-load hit 33.29% over its 30% trigger; cure by harvesting the two most concentrated AI names (SCCO copper-ATH, TSM largest compute) into cash. Funders all

Unlike last week's re-affirm, this run's entry weights are HIGHER than live for the AI names (SCCO 9.21 vs 8.30, TSM 7.55 vs 7.28), so re-affirming would have PUSHED AI-load up — the opposite of the cure. That flips my usual 'hold entry weights, let mechanical layer self-correct' default: this time the cure genuinely requires trimming below live. I leaned the harvest into SCCO (copper ATH, briefing flags it) and modestly into TSM (best anchor, so a light -2pp right-size, not a gut). Tension: proceeds can't redeploy under stale_policy, so cash climbs above the 15% ceiling and normalization may

Positions (18)

• MUMicron Technologycompute

  hold3.94%87
  flow acceleratingconf

  Funder

  Durable US HBM3E/HBM4 memory franchise, 84.6% GM, FCF+, capacity-disciplined cycle. Named flow: 16 Strategic Customer Agreements (~$100B contracted through 2030), Anthropic multi-year supply deal, ~$725B 2026 hyperscaler capex; Morgan Stanley 25% memory-price forecast + TSMC 2027 price hikes validate the shortage. Score 87, +10 drift — pillar's strongest momentum.

  Unwind

  DRAM/NAND spot-price collapse or HBM oversupply breaking the shortage thesis; hyperscaler capex cut; SCA contract-book erosion.

  Catalyst

  Next earnings HBM4 ramp + FY guide; hyperscaler memory allocation disclosures.

  Scenarios · 12mo targets

  $185.00 base

  $240.00 bull — HBM4 sold out through 2027, memory prices +25%, SCA book expands — DRAM super-cycle re-rates the multiple.

  $115.00 bear — Memory spot rolls over, HBM oversupply in 2027, hyperscaler capex decelerates.

• TSMTaiwan Semiconductor Manufacturingcompute

  trim5.73%-2.00pp86
  flow acceleratingconf

  Funder

  World-leading foundry, effective monopoly at <=3nm — every meaningful AI accelerator routes through TSMC. >50% GM, prodigious FCF, disciplined capex; 73% foundry share, $100B Arizona buildout, 10% 2027 price hikes. Goldman's $920B-$1.4T 2027 AI-capex forecast names TSMC explicitly. Score 86, thesis strengthening.

  Unwind

  Gross margin sustained <50% for two consecutive quarters; a rival closing the leading-edge yield gap.

  Catalyst

  Monthly revenue prints; 2027 pricing/capex commentary.

  Scenarios · 12mo targets

  $320.00 base

  $410.00 bull — AI-capex forecasts hold, 2027 price hikes stick, N2 ramps clean — foundry monopoly compounds.

  $230.00 bear — AI-capex deceleration in 2027, margin pressure from Arizona ramp, geopolitical Taiwan premium widens.

• NVDANVIDIAcompute

  hold3.68%74
  flow steadyconf

  Funder

  AI-accelerator monopoly with CUDA software moat, ~75% GM, fortress balance sheet. Named flow: ~$725B 2026 hyperscaler capex on Blackwell/Rubin (MSFT/AMZN/GOOGL/META), Stargate $500B JV; Q1 data-center rev $81.6B, +85% YoY. Already de-risked from 8.8% to 3.4%. Score 72 (weakening on valuation/ASIC-share, not fundamentals).

  Unwind

  Data-center revenue YoY <20% for two consecutive quarters; hyperscaler in-sourcing materially displacing GPU share.

  Catalyst

  Next earnings data-center run-rate; hyperscaler capex guide revisions.

  Scenarios · 12mo targets

  $175.00 base

  $230.00 bull — Rubin cycle extends the monopoly, inference demand broadens, capex holds — re-rates back above 80 conviction.

  $110.00 bear — ASIC in-sourcing bites, 2027 capex cut, DC growth decelerates below 20% two quarters.

• ASMLASML Holdingcompute

  hold2.91%61
  flow steadyconf

  Funder

  EUV/High-NA monopoly — only viable path to leading-edge logic, ~50% GM, multi-year backlog. Norway GPFG holds, Coatue/Third Point added Q1; TSMC/Samsung/Intel 2025-27 EUV orderbook backstops cash flow; 30% 2027 capacity increase. Already cut from 7.9% to 2.7%. Score 64 (weakening — valuation-stretched after +87% H1).

  Unwind

  Book-to-bill <0.7 for three consecutive quarters; forward P/E stretching toward >45x on a bookings deceleration.

  Catalyst

  Quarterly bookings/book-to-bill; High-NA shipment cadence.

  Scenarios · 12mo targets

  $900.00 base

  $1,150.00 bull — High-NA orderbook accelerates, TSMC/Intel capex holds — monopoly pricing power reasserts.

  $650.00 bear — Bookings decelerate, China restrictions bite, the +87% H1 multiple compresses.

• AVGOBroadcomcompute

  hold2.98%63
  flow steadyconf

  Funder

  Custom-silicon ASIC leader (~70% share) + VMware software moat, huge FCF, $7B+ annual buyback, serial dividend grower. GOOG TPU, META MTIA (1+GW), Anthropic ASIC contracts; AI segment +143% to $10.8B, $30B+ bookings. Already halved from 5.7% to 2.7%. Score 62 (weakening on Marvell competitive framing).

  Unwind

  AI custom-chip revenue stalls below $25B annual run-rate; full hyperscaler in-sourcing displaces the ASIC franchise.

  Catalyst

  Next earnings custom-silicon run-rate guide; Meta/Google ASIC ramp disclosures.

  Scenarios · 12mo targets

  $1,650.00 base

  $2,050.00 bull — ASIC bookings re-accelerate, VMware margin expansion, buyback shrinks float — AI-infra leverage compounds.

  $1,150.00 bear — Marvell/in-sourcing erode custom-silicon share, AI segment guide not raised.

• ANETArista Networkscompute

  hold2.65%67
  flow steadyconf

  Funder

  Arista — durable hyperscaler-networking franchise, share-gainer since 2004, ~62% GM, net cash, single-image EOS software moat, Ullal-led capital discipline. Microsoft & Meta named as largest customers funding ~30% YoY growth; Morgan Stanley OW, PT $190; AI-driven sales expected >50%. Score 67, stable.

  Unwind

  Microsoft+Meta combined concentration >50% with revenue decelerating; Spectrum-X/whitebox displacement of EOS.

  Catalyst

  Next earnings AI-networking mix; hyperscaler 800G/1.6T buildout cadence.

  Scenarios · 12mo targets

  $205.00 base

  $260.00 bull — AI back-end networking share widens, EOS lock-in deepens, guidance raised a third straight quarter.

  $140.00 bear — Hyperscaler concentration risk crystallizes, HPE/Juniper competition dents bookings.

• CCJCamecoenergy

  hold6.86%67
  flow steadyconf

  Funder

  Tail-risk hedge slot: tier-1 Saskatchewan uranium franchise + Westinghouse 49% JV with Brookfield. Trump EO targeting 400GW US nuclear by 2050 expands contracted demand; Kazatomprom 8Mlb output cut sustains a structural deficit; term U3O8 $94-95.50/lb vs $60+ contract book. Score 65, thesis intact (RSI 36, oversold).

  Unwind

  Uranium spot/term price collapse; contract-book erosion; a reactor-build program cancellation. Score drift alone is not a trim trigger.

  Catalyst

  Term uranium price prints; utility contracting cadence; Westinghouse AP1000 order flow.

  Scenarios · 12mo targets

  $72.00 base

  $95.00 bull — Term uranium breaks higher on deficit, AP1000/SMR order wave, hyperscaler nuclear PPAs multiply.

  $48.00 bear — Spot/term uranium rolls over, contracting stalls, Kazatomprom restores output.

• GEVGE Vernovaenergy

  hold4.96%61
  flow acceleratingconf

  Funder

  Gas-turbine + grid franchise with pricing power — ~$163B backlog (3.5+ yrs sales), turbines sold out through 2030, 10-20% price realization, quadrupled FCF. Norway GPFG added post-spin; Oracle/Alphabet/xAI datacenter capex pull-through; Chevron JV behind-the-meter. Score 63, raised 2026 guidance.

  Unwind

  Backlog cancellation or wind-segment deterioration; EV/EBITDA breaching ~25x exit ceiling; a hyperscaler power-capex cut.

  Catalyst

  Order-book disclosure; wind-segment update; potential Dow inclusion.

  Scenarios · 12mo targets

  $560.00 base

  $700.00 bull — Turbine slots sold through 2031, price realization widens, grid backlog compounds on AI-power demand.

  $390.00 bear — Datacenter power-capex cut, wind losses persist, the 533%/2yr multiple compresses.

• SCCOSouthern Copperenergy

  trim6.81%-3.00pp68
  flow steadyconf

  Funder

  Tail-risk hedge slot: lowest-cost copper producer, vast reserves, fat margins, large dividend. Copper supply deficit ~320k tonnes 2026, prices near record highs; AI/datacenter ~30% of new copper demand by 2030 (BloombergNEF); Mexican-gov ownership backstop. Score 63, +5 drift. Trimming to harvest copper strength and cure the §2 AI-load concentration breach — thesis fully intact.

  Unwind

  Copper price collapse breaking the deficit thesis; Tia Maria/Los Chancas permitting reversal; dividend cut.

  Catalyst

  Copper spot prints; Tia Maria/Los Chancas project milestones; quarterly NI.

  Scenarios · 12mo targets

  $115.00 base

  $145.00 bull — Copper deficit widens on grid + AI-DC demand, project additions ramp — structural cycle re-rates.

  $80.00 bear — China demand slump or recession breaks copper, projects slip, dividend trimmed.

• MPMP Materialsenergy

  hold2.95%44
  flow softeningconf

  Funder

  Only scaled US rare-earth + magnet producer; DoD $400M Series A preferred + $150M loan + 10-yr $110/kg NdPr price floor + 10-yr magnet offtake for the 10X facility — a government-backstopped moat vs China's 98% magnet control. Apple long-term contract, SpaceX/Trump support tape. Already tiny (2.30%) and twice-trimmed — churn-trimming further is the pattern to avoid.

  Unwind

  FCF stays negative through the magnet ramp; China blacklist chokes processing-tech access materially; 10X construction slips; DoD backstop withdrawn.

  Catalyst

  10X Texas magnet facility construction milestones; DoD funding tranches; NdPr pricing.

  Scenarios · 12mo targets

  $32.00 base

  $50.00 bull — 10X magnet ramp executes, DoD floor + Apple offtake anchor cash flow, US supply-chain premium re-rates.

  $18.00 bear — China blacklist chokes processing tech, FCF stays negative, 10X construction slips.

• NEMNewmont Corporationenergy

  hold6.63%88
  flow steadyconf

  Funder

  Tail-risk equity hedge (§5.3): largest gold producer, tier-1 long-life assets, strong post-Newcrest FCF and dividend, improving cost discipline. Central-bank gold accumulation; TD Cowen upgrade (hold->buy, July 14) on valuation; structural hedge against frozen-Fed stagflation. Score 88-89, highest-conviction energy-pillar name.

  Unwind

  Cost overruns / mine disappointments break FCF and dividend; durable disinflation removes the stagflation-hedge rationale.

  Catalyst

  Gold price prints; quarterly AISC/FCF; divestiture progress.

  Scenarios · 12mo targets

  $72.00 base

  $95.00 bull — Gold sustains record highs on central-bank buying + real-rate fall, cost discipline lifts FCF and dividend.

  $52.00 bear — Gold rolls over on a hawkish Fed, mine cost overruns re-emerge post-Newcrest.

• KTOSKratos Defensedefense

  hold11.11%62
  flow steadyconf

  Funder

  DoD MACH-TB 2.0 IDIQ prime ($1.45B ceiling, 5-yr); Project Helios $68.3M hypersonic-materials single-award; USMC XQ-58A Valkyrie mods; Pentagon Unleash American Drone Dominance program (22K+ units). ARK added 138K shares late June; $2B+ backlog 72% funded, 20%+ growth expected. Out-of-scope this patch — held verbatim.

  Unwind

  Backlog/contract cancellations; margin failing to inflect through the drone ramp; a DoD drone-program funding cut.

  Catalyst

  Drone-program task orders; hypersonics milestones; margin-inflection print.

  Scenarios · 12mo targets

  $95.00 base

  $130.00 bull — Drone-dominance procurement scales, Valkyrie/hypersonics backlog converts, margins inflect.

  $55.00 bear — Contract delays, margin ramp stalls, competitive encroachment in tactical drones.

• HEIHEICOdefense

  hold10.30%68
  flow steadyconf

  Funder

  Defense/aero aftermarket compounder — Mendelson family owners since 1957, 20%+ FCF CAGR, disciplined serial acquirer ($1B+/yr). Record Q2 net income +49% YoY, ETG op income +56%; NDAA mandatory funding + commercial-aerospace MRO; Wencor integration accretive. Out-of-scope this patch — held verbatim. Score 68.

  Unwind

  Organic growth decelerates below 6% with margin compression; forward P/E sustained above 50x with growth deceleration confirmed.

  Catalyst

  Next quarter FSG/ETG segment prints; acquisition tape cadence.

  Scenarios · 12mo targets

  $340.00 base

  $420.00 bull — Aftermarket demand + acquisition tape compounds double-digit, ETG margins expand, PT raises continue.

  $250.00 bear — Air-traffic slowdown hits aftermarket, 54x P/E compresses on any growth wobble.

• PSNParsons Corporationdefense

  hold3.59%59
  flow softeningconf

  Funder

  Parsons — C5ISR/cyber government-services prime, sticky multi-year IDIQ backlog: MDA SHIELD $151B-ceiling IDIQ, DTRA cyber $137M, USAF MATOC $15B, Navy WEXMAC $10B; Cyber Hunt Kit $500M, $125M Army AI/ML task order; Lusail Qatar + Blatnik Bridge civil wins. Out-of-scope this patch — held verbatim. Score weak (50).

  Unwind

  Book-to-bill falls below 1.0 two consecutive quarters; confidential-contract revenue softness persists blocking backlog conversion.

  Catalyst

  2026 guidance execution; SHIELD task-order conversion; book-to-bill print.

  Scenarios · 12mo targets

  $75.00 base

  $95.00 bull — SHIELD/MDA task orders convert, cyber backlog ramps, confidential-contract softness reverses.

  $52.00 bear — Book-to-bill stays sub-1.0, earnings misses recur, backlog conversion stalls.

• LLYEli Lillybiology

  hold4.81%73
  flow steadyconf

  Funder

  Premier pharma compounder — Mounjaro/Zepbound GLP-1 franchise (~60% US share) + oral orforglipron (Foundayo, FDA-approved) + retatrutide Ph3 (~70lb loss); 82.9% GM, FCF+, $27B manufacturing expansion, AtaiBeckley pipeline add. Domestic-manufacturing tilt favored by July 31 pharma tariff. Out-of-scope this patch — held verbatim. Score 70.

  Unwind

  Tirzepatide US script share falls >5pts to NVO over two quarters; retatrutide Ph3 disappoints; IRA negotiation hits the franchise.

  Catalyst

  July 31 pharma tariff; orforglipron launch; retatrutide Ph3 readouts.

  Scenarios · 12mo targets

  $950.00 base

  $1,200.00 bull — Oral orforglipron + retatrutide extend the GLP-1 monopoly, capacity ramps, script share holds.

  $680.00 bear — NVO oral Wegovy takes share, IRA negotiation cuts pricing, GLP-1 category multiple compresses.

• VRTXVertex Pharmaceuticalsbiology

  hold3.22%81
  flow steadyconf

  Funder

  Durable biology compounder: cystic-fibrosis monopoly (Trikafta) cash engine, self-funded, 86.8% GM, fortress balance sheet. Casgevy commercializing across 12+ jurisdictions; Journavx non-opioid optionality; $10B Crinetics acquisition diversifies into endocrine. GPFG/large AM holders. Out-of-scope this patch — held verbatim. Locked 14d (unlock=none). Score 76.

  Unwind

  CF franchise erodes faster than non-CF revenue can replace; Crinetics integration destroys value; pipeline setbacks.

  Catalyst

  Crinetics/Palsonify integration; Journavx uptake; Casgevy reimbursement expansion.

  Scenarios · 12mo targets

  $520.00 base

  $640.00 bull — Non-CF pipeline (Journavx, Crinetics endocrine) diversifies the cash engine, CF monopoly holds.

  $400.00 bear — CF erosion outpaces new launches, Crinetics premium (102%) proves value-destructive.

• ARGXargenxbiology

  hold2.89%70
  flow acceleratingconf

  Funder

  argenx — Vyvgart/Vyvgart Hytrulo (efgartigimod) autoimmune FcRn franchise; self-funded commercial-stage, high-margin, net cash. FDA expanded gMG approval to all serotypes (18% TAM expansion); Sanofi riliprubart Ph3 failure strengthens the CIDP moat; myositis/Sjogren pipeline advancing. Out-of-scope this patch — held verbatim. Locked 15d (unlock=none). Score 70.

  Unwind

  Vyvgart revenue growth stalls; a pipeline indication failure; a competitor FcRn entrant taking share.

  Catalyst

  CIDP/MMN/SjD label expansions; quarterly Vyvgart revenue ramp.

  Scenarios · 12mo targets

  $720.00 base

  $900.00 bull — Vyvgart scales across indications ($6B->$16B TAM), CIDP moat widens post-Sanofi, pipeline reads out.

  $540.00 bear — Vyvgart growth decelerates, a pipeline indication fails, FcRn competition emerges.

• LUNRcompute

  hold1.28%54
  flow steadyconf

  Funder

  Intuitive Machines — NASA Near Space Network IDIQ $4.82B ceiling (active); CLPS $148.3M firm task order; US Space Force Andromeda IDIQ $6.2B ceiling; $428.9M Q1 2026 contracts from SDA+NASA; $1.1B backlog, $1B FY26 revenue guide. Out-of-scope this patch — held verbatim. Locked 24d (unlock=[B] only). Score 54.

  Unwind

  Backlog conversion stalls; profitability pathway breaks; NASA/SDA program funding cut; further insider selling.

  Catalyst

  CLPS mission execution; SDA/NASA task-order flow; profitability-pathway prints.

  Scenarios · 12mo targets

  $14.00 base

  $22.00 bull — Backlog converts to $1B revenue, profitability pathway confirms, space-infra rotation lifts smaller peers.

  $8.00 bear — Mission execution slips, cash burn persists, 28% short interest presses on binary sector risk.

Warnings

• §2 cap re-applied after pillar tilt: MU
• §2 cap re-applied after pillar tilt: TSM
• §2 cap re-applied after pillar tilt: NVDA
• §2 cap re-applied after pillar tilt: ASML
• §2 cap re-applied after pillar tilt: AVGO
• §2 cap re-applied after pillar tilt: ANET
• §2 cap re-applied after pillar tilt: CCJ
• §2 cap re-applied after pillar tilt: GEV
• §2 cap re-applied after pillar tilt: LUNR
• hedge_floor: only 2/3 tail-risk names held (floor escalated: AI-load 35% > 30%) — open a gold/oil/diversified-commodity hedge (§5.3); uranium & power-gen do not count

Conviction-lock actions

No conviction-lock refusals or overrides this run.

Cost breakdown

Per-call cost computed from cost.js pricing constants (Opus 4.7, Sonnet 4.6, Haiku 4.5). Cache-read tokens billed at 10% of input. See Cost & ROI for the rolling 30-day ledger.